One Bill, One Subject Transparency ActThis bill prohibits any bill or joint resolution from addressing more than one subject and establishes related enforcement mechanisms.The bill requires bills and joint resolutions to address only one subject, which must be clearly and descriptively expressed in the bill or joint resolution's title. Appropriations bills may only contain provisions that are germane to the subject matter of the underlying bill. However, appropriations bills may limit the expenditure of appropriated funds.The bill voids any act (i.e., law) or joint resolution with a title that addresses two or more unrelated subjects;any provision of an act or joint resolution concerning a subject that is not clearly and descriptively expressed in the title;any provision of an appropriations act that contains general legislation or change of existing law provision not germane to the subject matter of the underlying bill;any provision of an appropriations act that addresses a subject outside of the jurisdiction of the relevant subcommittee of the Committees on Appropriations of the House and of the Senate.The bill also authorizes any person aggrieved by the enforcement or threat of enforcement of an act enacted after this bill that does not comply with the requirements of this bill to sue the United States.
Protecting Dogs Subjected to Experiments Act This bill prohibits the National Institutes of Health from funding biological, medical, or behavioral research that involves testing dogs.
Diagnostics Testing Preparedness Plan Act of 2025
An Act Concerning Medicaid Coverage Of Noninvasive, Custom Breast Prostheses For Mastectomy Patients.
An Act Concerning Registration Fees For Diagnostic And Therapeutic X-ray Devices .
Jobs and Opportunities for Medicaid Act This bill establishes work requirements under Medicaid for able-bodied adults. Specifically, the bill requires individuals who are between the ages of 18 and 65 and who are not otherwise unable to work due to a medical condition, family situation, or other listed reason to work or volunteer at least 20 hours per week, based on a monthly average, in order to qualify for Medicaid.
Protecting Life on College Campus Act of 2025This bill prohibits the award of federal funds to an institution of higher education (IHE) that hosts or is affiliated with a school-based service site that provides abortion drugs or abortions to its students or to employees of the IHE or the site. An IHE that hosts or is affiliated with a site must, in order to remain eligible for federal funds, annually certify that the site does not provide abortion drugs or abortions to students or employees.
The HCT/P Modernization Act of 2025This bill requires the Food and Drug Administration (FDA) to provide information to stakeholders and report on the regulation of human cell and tissue products, also referred to as human cells, tissues, or cellular or tissue-based products (HCT/Ps), which are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.The bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion with them on advancing the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and submit to Congress a report with recommendations on regulating these products. Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group and best practices for obtaining a recommendation about products from them. Also, annually for three years, the FDA must publish on its website information on the inquiries submitted and average response times for the Tissue Reference Group, as well as the number of human cell and tissue manufacturers that have registered with the FDA and the number of inspections the FDA has conducted with respect to these manufacturers since 2019. (The Tissue Reference Group is a working group within the FDA that receives product-specific questions from, and provides recommendations for, stakeholders on the regulation of human cell and tissue products under the FDA’s rules.)
Prompt Approval of Safe Generic Drugs ActThis bill authorizes the Food and Drug Administration (FDA) to approve certain applications to market a generic drug despite the omission of certain safety information from the generic drug's labeling.Specifically, the FDA may not deem an abbreviated application for approval of a generic drug ineligible for approval solely because the drug's labeling omits safety information that is protected under another drug's patent or exclusivity protections. Similarly, a drug that is approved under this bill may not be considered mislabeled for lacking such safety information.Generally, an abbreviated application, for the purposes of this bill, is one that (1) uses required information from studies not conducted by the applicant; or (2) seeks approval of a drug that is, for drug approval purposes, a duplicate of an already-approved drug (i.e., a generic drug). Currently, the labeling for such a generic drug must generally be identical to that of the already-approved drug. This bill provides an exception to that requirement under the specified circumstances. For any drug approved under this bill, the FDA must require the drug's labeling to include any safety information that is necessary to assure safe use.
Jobs and Opportunities for Medicaid Act This bill establishes work requirements under Medicaid for able-bodied adults. Specifically, the bill requires individuals who are between the ages of 18 and 65 and who are not otherwise unable to work due to a medical condition, family situation, or other listed reason to work or volunteer at least 20 hours per week, based on a monthly average, in order to qualify for Medicaid.